# Moxifloxacin Versus Ceftriaxone in the Treatment of Primary Pyogenic Liver Abscess

> **NCT00895089** · PHASE4 · COMPLETED · sponsor: **Kaohsiung Veterans General Hospital.** · enrollment: 24 (actual)

## Conditions studied

- Liver Abscess

## Interventions

- **DRUG:** Moxifloxacin (Avelox)
- **DRUG:** ceftriaxone

## Key facts

- **NCT ID:** NCT00895089
- **Lead sponsor:** Kaohsiung Veterans General Hospital.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2010-12
- **Final completion:** 2011-12
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2015-12-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00895089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00895089, "Moxifloxacin Versus Ceftriaxone in the Treatment of Primary Pyogenic Liver Abscess". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00895089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*